Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MMED
HOLDMiniMed Group, Inc. · Healthcare · United States · $4.7B · Avg Vol: $22M/d
COMPANY DESCRIPTION
Minimed Group, Inc. is a healthcare company focused on the development and commercialization of medical products or services, likely within a specialized therapeutic area or medical device segment. The company aims to differentiate through innovation and targeted solutions that address specific patient needs. Its success hinges on clinical validation, regulatory approvals, and effective market penetration in a competitive healthcare landscape.
FINANCIAL SUMMARY (USD)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.2B | 2.5B | 2.7B | 3.1B | 11.4% | 3.1B | 3.6B | 3.9B | 11.9% |
| EPS | -0.34 | -0.40 | -0.76 | -1.30 | — | -1.30 | — | — | — |
| Shares | — | 280.8M | 280.8M | 280.8M | +0.0% | 280.8M | — | — | — |
| Debt | — | 8.0M | 11.0M | 145.0M | 325.7% | 53.0M | — | — | — |
| Equity | — | 3.4B | 3.3B | 3.6B | 2.3% | — | — | — | — |
| Op CF | -6.0M | 41.0M | 140.0M | -197.0M | 241.5% | -197.0M | — | — | — |
| Inv CF | -180.0M | -157.0M | -193.0M | -233.0M | — | — | — | — | — |
| Fin CF | 185.0M | 112.0M | 10.0M | 716.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MMED are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MMED | MiniMed Group, Inc.(you) | $4.7B | 37 | HOLD |
| RGEN | Repligen Corporation | $7.4B | 40 | HOLD |
| WRBY | Warby Parker Inc. | $3.0B | 42 | HOLD |
| PLSE | Pulse Biosciences, Inc. | $2.1B | 24 | SELL |
| AZTA | Azenta, Inc. | $1.3B | 44 | HOLD |
| TFX | Teleflex Incorporated | $5.8B | 69 | BUY |
| AVTR | Avantor, Inc. | $7.8B | 64 | HOLD |
| COO | The Cooper Companies, Inc. | $13.7B | 53 | HOLD |
| ATRC | AtriCure, Inc. | $1.8B | 55 | HOLD |
| KMTS | Kestra Medical Technologies, Ltd. | $1.2B | 23 | SELL |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.5%